The deal is with drugmakers Eli Lilly and Novo Nordisk to cut prices of their weight-loss drugs and expand Medicare coverage ...
Access to the drugs has been a consistent problem for patients because of their cost — around $500 a month for higher doses — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback